Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Analyst Sarah James Reaffirms Underweight Rating for Universal Health Services

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Finance_Financing
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On March 5, 2024, Sarah James, an analyst at Cantor Fitzgerald, restated her assessment of Universal Health Services (NYSE: UHS) with a rating of Underweight and a price target of $156. This reaffirmation reflects James’ view on how the stock is expected to fare compared to others in its industry. ___

Universal Health Services (UHS) Stock Shows Strength with Positive Trading Day on March 5, 2024

On March 5, 2024, Universal Health Services (UHS) experienced a positive trading day as its stock price showed signs of strength. UHS is currently trading near the top of its 52-week range and above its 200-day simple moving average, indicating a bullish trend. The price of UHS shares increased by $0.51 on March 5, representing a 0.29% rise from the previous trading day. Despite opening lower at $173.73, UHS managed to recover and end with a positive gain. Investors may have been encouraged by UHS’s strong performance on March 5, especially considering the challenges faced by the healthcare sector. It is important for investors to continue monitoring UHS’s stock performance to see if the positive momentum can be sustained. Overall, UHS’s stock performance on March 5, 2024, was a bright spot in an otherwise turbulent market, indicating potential future growth and success in the healthcare sector.

Universal Health Services (UHS) Stock Shows Promising Performances: Financial Analysis and Outlook

On March 5, 2024, Universal Health Services (UHS) stock showed promising performances based on the financial data provided by CNN Money. The company reported a total revenue of $14.28 billion for the past year, with a quarterly revenue of $3.70 billion. In terms of net income, UHS reported a net income of $717.49 million for the past year, with a quarterly net income of $216.31 million. Furthermore, the earnings per share (EPS) for UHS were reported at $10.23 for the past year and $3.16 for the last quarter. Overall, these financial indicators suggest that UHS has been performing well in terms of revenue, net income, and earnings per share. The consistent growth in revenue and net income over the past year reflects positively on the company’s financial health and stability. Additionally, the increase in EPS indicates that UHS is generating more profits for its shareholders. Investors and analysts may view these positive financial performances as a good sign for UHS stock. However, it is essential to conduct further research and analysis before making any investment decisions based on this information.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Financing

Stifel Analyst Nathan Jones Reaffirms Buy Rating for Parker Hannifin

Tech-Innovations

Addressing the Chip Engineer Shortage in Japan PSMCs Innovative Initiative

Entertainment Markets and money

Revitalizing Marvel Bob Igers Commitment to Excellence

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com